Country: অস্ট্রেলিয়া
ভাষা: ইংরেজি
সূত্র: Department of Health (Therapeutic Goods Administration)
mercaptopurine monohydrate, Quantity: 50 mg
Aspen Pharmacare Australia Pty Ltd
mercaptopurine monohydrate
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch
Oral
25 tablets
(S4) Prescription Only Medicine
INDICATIONS AS AT 5 March 2004: Treatment of leukemia. It is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. MERCAPT is also used in the treatment of chronic granulocytic leukaemia.
Visual Identification: Pale yellow, round, biconvex tablets, marked PT above the line and 50 below the line on one side and plain on the other.; Container Type: Bottle; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-09-21